Cardiovascular ultrasound sales will strengthen through 2036, anchored by transthoracic echocardiography at 71.3% of the type segment in 2026. The market was valued at USD 1.42 billion in 2025 and is expected to be worth USD 2.93 billion by 2036, creating an incremental opportunity of USD 1.41 billion between 2026 and 2036.